Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
多模式干预改善脊髓损伤的功能和代谢
基本信息
- 批准号:10764596
- 负责人:
- 金额:$ 44.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-21 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:Administrative SupplementAerobicAnxietyApplications GrantsAreaBone DensityCOVID-19 pandemicCaregiver BurdenClinical ResearchEnrollmentErgometryExerciseFPS-FES OncogeneFatty acid glycerol estersFundingGrantHealthHealthcareHomeHybridsImpairmentInterventionInvestmentsLifeLipidsMedical centerMetabolicMetabolismMonitorMoodsMusculoskeletalPainParentsParticipantPatient Self-ReportPersonal SatisfactionPersonsPharmacologic SubstancePhysical PerformancePhysiologicalPlacebosRampRandomizedRecovery of FunctionRequest for ApplicationsResearchResearch ActivityResourcesSpinal cord injurySpinal cord injury patientsSuspensionsTestingTestosteroneTrainingTranslatingUnited States National Institutes of Healthage stratificationarmbody systemboneclinical practicecomputerizedcoronavirus diseasecostdesignefficacy evaluationexercise trainingfunctional improvementimprovedindexinginflammatory markerinnovationinsulin sensitivitylaboratory experimentmotor function improvementmulti-component interventionmultimodalitymuscle formmuscle strengthprimary outcomeprogramsrandomized placebo controlled trialrandomized trialrehabilitation researchsatisfactionsecondary outcomesex
项目摘要
Abstract
This application for an administrative supplement requests approval for a one-year extension with partial
funding to enable the completion of this ongoing randomized trial that is currently in its fifth year of funding.
The funded trial aims to test the hypothesis that a multi-modality intervention that includes hybrid exercise plus
testosterone and targets deficits in multiple physiologic organ systems will be more efficacious in improving
musculoskeletal and metabolic health and wellbeing of people living with SCI than hybrid excise plus placebo.
This hypothesis is being tested in a randomized trial in 88 persons with C7 to T12 SCI, AIS grade A, B or C, 6
months or later after SCI. Participants are being randomized to either the multi-modality intervention or hybrid
exercise plus placebo for 16 weeks, stratified by age, sex, and AIS grade. After 2-weeks of training in the
exercise laboratory, the intervention is conducted in the participant’s home, using video monitoring of the home
exercise. Primary outcome is peak aerobic capacity. Secondary outcomes include self-reported function and
mobility assessed using computerized adaptive test version of Spinal Cord Injury-Functional Index; muscle
mass and strength; fat mass and fat distribution; insulin sensitivity; lipids; inflammatory markers; and wellbeing
(mood, anxiety, pain, and life satisfaction). The aims or the design of the funded trial have not changed.
Very shortly after the trial's initiation, the sudden onset of the COVID pandemic led to nationwide shutdown of
most non-covid clinical research activities. Due to the complete shutdown of clinical research for several
months in 2022 followed by slow ramp up of clinical research activities in 2020 and 2021 due to multitude of
factors that are discussed in the application, the enrollment in the trial suffered. In spite of these COVID-related
challenges, the enrollment in the trial during the past year has increased substantially and the current
enrollment rate exceeds that projected in the original grant application. Therefore, the parent as well as the
supplemental bone study are on target for completion in the coming year. An additional year of partial support
of the project would enable completion and close-out of the trial, accomplishment of all the proposed aims of
the project, and accrual of full returns on the NIH's generous investment in this important project of high priority
to people living with a SCI.
Spinal cord injury (SCI) is one of the most grievous conditions that greatly impairs a person's mobility, function,
overall health, and wellbeing, and increases healthcare resource utilization and costs and caregiver burden.
The National Center for Medical Rehabilitation research has designated “pharmaceutical, stimulation, and
exercise…strategies to improve motor function and health of SCI patients” a priority area of research. Because
all components of the multimodality intervention are commercially available, the findings of this innovative trial
upon its completion could be expeditiously translated into clinical practice and improve the health and
wellbeing of people with SCI.
摘要
本行政补充申请要求批准延期一年,
资助,以使这项正在进行的随机试验,目前是在其第五年的资金完成。
这项资助的试验旨在检验一种假设,即一种包括混合运动加
睾酮和多个生理器官系统中的靶缺陷将更有效地改善
脊髓损伤患者的肌肉骨骼和代谢健康和幸福感。
在一项随机试验中,88名C7至T12 SCI患者,AIS A、B或C级,6
SCI后3个月或更长时间。参与者被随机分配到多模态干预或混合干预组。
运动加安慰剂16周,按年龄、性别和AIS分级分层。经过2周的培训,
运动实验室,干预是在参与者的家中进行,使用家庭视频监控
锻炼的主要结果是峰值有氧能力。次要结局包括自我报告的功能,
使用脊髓损伤功能指数的计算机化自适应测试版本评估活动性;肌肉
体重和力量;脂肪量和脂肪分布;胰岛素敏感性;脂质;炎症标志物;和健康
(mood焦虑、疼痛和生活满意度)。受资助试验的目的或设计没有改变。
在试验开始后不久,新冠肺炎疫情的突然爆发导致全国范围内关闭了
大多数非新冠肺炎临床研究活动。由于几年来临床研究的完全关闭,
2020年及2021年的临床研究活动缓慢增加,原因是
在申请中讨论的因素,在试验中的招募受到影响。尽管这些与COVID相关的
挑战,在过去一年中,试验的入组人数大幅增加,目前
入学率超过了最初的补助金申请中的预测。因此,父母以及
补充骨骼研究可望于明年完成。额外一年的部分支助
该项目的实施将有助于完成和结束审判,实现所有拟议目标,
该项目,以及国家卫生研究院在这一重要的高优先级项目上的慷慨投资的全部回报
给脊髓损伤患者
脊髓损伤(SCI)是最严重的疾病之一,极大地损害了一个人的行动能力,功能,
总体健康和福祉,并增加医疗保健资源利用和成本以及护理人员负担。
国家医疗康复研究中心已指定“药物,刺激,
运动.改善脊髓损伤患者运动功能和健康的策略”是优先研究领域。因为
多模式干预的所有组成部分都可以在市场上买到,这项创新试验的结果
完成后,可以迅速转化为临床实践,改善健康,
SCI患者的健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHALENDER BHASIN其他文献
SHALENDER BHASIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHALENDER BHASIN', 18)}}的其他基金
NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
NAD 增强治疗糖尿病肾病:一项随机对照试验
- 批准号:
10430705 - 财政年份:2022
- 资助金额:
$ 44.64万 - 项目类别:
NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
NAD 增强治疗糖尿病肾病:一项随机对照试验
- 批准号:
10668324 - 财政年份:2022
- 资助金额:
$ 44.64万 - 项目类别:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
Sirtuin-NAD 激活剂治疗阿尔茨海默病的概念验证试验
- 批准号:
10311161 - 财政年份:2021
- 资助金额:
$ 44.64万 - 项目类别:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
Sirtuin-NAD 激活剂治疗阿尔茨海默病的概念验证试验
- 批准号:
10457489 - 财政年份:2021
- 资助金额:
$ 44.64万 - 项目类别:
A Proof of Concept Trial of a Sirtuin-NAD+ Activator in Alzheimer's Disease
Sirtuin-NAD 激活剂治疗阿尔茨海默病的概念验证试验
- 批准号:
10634622 - 财政年份:2021
- 资助金额:
$ 44.64万 - 项目类别:
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
改善雄激素缺乏的前列腺癌幸存者的生活质量
- 批准号:
10398005 - 财政年份:2018
- 资助金额:
$ 44.64万 - 项目类别:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
多模式干预改善脊髓损伤的功能和代谢
- 批准号:
9767249 - 财政年份:2018
- 资助金额:
$ 44.64万 - 项目类别:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
多模式干预改善脊髓损伤的功能和代谢
- 批准号:
10159744 - 财政年份:2018
- 资助金额:
$ 44.64万 - 项目类别:
Multimodality Intervention to Improve Function and Metabolism in Spinal Cord Injury
多模式干预改善脊髓损伤的功能和代谢
- 批准号:
10398790 - 财政年份:2018
- 资助金额:
$ 44.64万 - 项目类别:
Improving Quality of Life of Prostate Cancer Survivors with Androgen Deficiency
改善雄激素缺乏的前列腺癌幸存者的生活质量
- 批准号:
9918241 - 财政年份:2018
- 资助金额:
$ 44.64万 - 项目类别:
相似海外基金
Developing Late Metal Catalytic Systems for Aerobic Partial Oxidation of Alkanes
开发烷烃有氧部分氧化的后金属催化系统
- 批准号:
2247667 - 财政年份:2023
- 资助金额:
$ 44.64万 - 项目类别:
Standard Grant
Targeting aerobic glycolysis via hexokinase 2 inhibition in Natural Killer T cell lymphomas
通过抑制己糖激酶 2 靶向自然杀伤 T 细胞淋巴瘤中的有氧糖酵解
- 批准号:
23K07830 - 财政年份:2023
- 资助金额:
$ 44.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Precision Medicine in Alzheimer’s Disease: A SMART Trial of Adaptive Exercises and Their Mechanisms of Action Using AT(N) Biomarkers to Optimize Aerobic-Fitness Responses
阿尔茨海默病的精准医学:使用 AT(N) 生物标志物优化有氧健身反应的适应性运动及其作用机制的 SMART 试验
- 批准号:
10581973 - 财政年份:2023
- 资助金额:
$ 44.64万 - 项目类别:
MIND Foods and Aerobic Training in Black Adults with HTN: An ADRD Prevention Pilot RCT (MAT)
MIND 食品和患有 HTN 的黑人成人的有氧训练:ADRD 预防试点随机对照试验 (MAT)
- 批准号:
10585366 - 财政年份:2023
- 资助金额:
$ 44.64万 - 项目类别:
Concurrent Aerobic Exercise and Cognitive Training to Prevent Alzheimer's in at-risk Older Adults
同时进行有氧运动和认知训练可预防高危老年人的阿尔茨海默病
- 批准号:
10696409 - 财政年份:2023
- 资助金额:
$ 44.64万 - 项目类别:
Investigating the physical and chemical controls on aerobic methane oxidation
研究好氧甲烷氧化的物理和化学控制
- 批准号:
2241873 - 财政年份:2023
- 资助金额:
$ 44.64万 - 项目类别:
Standard Grant
Effect of aerobic exercise-induced sleep changes on arterial stiffness associated with postprandial hyperglycemia.
有氧运动引起的睡眠变化对与餐后高血糖相关的动脉僵硬度的影响。
- 批准号:
23K10645 - 财政年份:2023
- 资助金额:
$ 44.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pro-Resolving Inflammatory Mediators in Neurovascular Gains in Aerobic Training; a phase 2, double-blind, randomized placebo-controlled trial (PRIMiNG-AT2)
有氧训练中促进神经血管增益的炎症介质的消除;
- 批准号:
485524 - 财政年份:2023
- 资助金额:
$ 44.64万 - 项目类别:
Operating Grants
Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease
视网膜健康和疾病中光感受器有氧糖酵解的调节因子
- 批准号:
10717825 - 财政年份:2023
- 资助金额:
$ 44.64万 - 项目类别:
The Effects of Aerobic Exercise on Cardiovascular Health in Postmenopausal Females: A Systematic Review and Meta-Analysis
有氧运动对绝经后女性心血管健康的影响:系统评价和荟萃分析
- 批准号:
480729 - 财政年份:2023
- 资助金额:
$ 44.64万 - 项目类别: